• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的血脑屏障与脑血管病理学

The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.

作者信息

Kalaria R N

机构信息

Institute for Health of the Elderly, Newcastle General Hospital, Newcastle upon Tyne, United Kingdom.

出版信息

Ann N Y Acad Sci. 1999;893:113-25. doi: 10.1111/j.1749-6632.1999.tb07821.x.

DOI:10.1111/j.1749-6632.1999.tb07821.x
PMID:10672233
Abstract

The pathology of Alzheimer's disease (AD) is not limited to amyloid plaques and neurofibrillary tangles. Recent evidence suggests that more than 30% of AD cases exhibit cerebrovascular pathology, which involves the cellular elements that represent the blood-brain barrier. Certain vascular lesions such as microvascular degeneration affecting the cerebral endothelium, cerebral amyloid angiopathy and periventricular white matter lesions are evident in virtually all cases of AD. Furthermore, clinical studies have demonstrated blood-brain barrier dysfunction in AD patients who exhibit peripheral vascular abnormalities such as hypertension, cardiovascular disease and diabetes. Whether these vascular lesions along with perivascular denervation are coincidental or causal in the pathogenetic processes of AD remains to be defined. In this chapter, I review biochemical and morphological evidence in context with the variable but distinct cerebrovascular pathology described in AD. I also consider genetic influences such as apolipoprotein E in relation to cerebrovascular lesions that may shed light on the pathophysiology of the cerebral vasculature. The compelling vascular pathology associated with AD suggests that transient and focal breach of the blood-brain barrier occurs in late onset AD and may involve an interaction of several factors, which include perivascular mediators as well as peripheral circulation derived factors that perturb the endothelium. These vascular abnormalities are likely to worsen cognitive disability in AD.

摘要

阿尔茨海默病(AD)的病理学并不局限于淀粉样斑块和神经原纤维缠结。最近的证据表明,超过30%的AD病例存在脑血管病理学改变,这涉及构成血脑屏障的细胞成分。某些血管病变,如影响脑内皮细胞的微血管变性、脑淀粉样血管病和脑室周围白质病变,在几乎所有AD病例中都很明显。此外,临床研究表明,患有外周血管异常(如高血压、心血管疾病和糖尿病)的AD患者存在血脑屏障功能障碍。这些血管病变以及血管周围去神经支配在AD发病过程中是巧合还是因果关系,仍有待确定。在本章中,我结合AD中描述的可变但独特的脑血管病理学,综述生化和形态学证据。我还考虑了遗传影响,如载脂蛋白E与脑血管病变的关系,这可能有助于阐明脑血管系统的病理生理学。与AD相关的令人信服的血管病理学表明,在晚发性AD中会发生血脑屏障的短暂性和局灶性破坏,可能涉及多种因素的相互作用,其中包括血管周围介质以及扰乱内皮细胞的外周循环衍生因子。这些血管异常可能会加重AD患者的认知障碍。

相似文献

1
The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.阿尔茨海默病中的血脑屏障与脑血管病理学
Ann N Y Acad Sci. 1999;893:113-25. doi: 10.1111/j.1749-6632.1999.tb07821.x.
2
Overlap between pathology of Alzheimer disease and vascular dementia.阿尔茨海默病与血管性痴呆的病理学重叠。
Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S115-23. doi: 10.1097/00002093-199912003-00017.
3
Vascular factors in Alzheimer's disease.阿尔茨海默病中的血管因素
Int Psychogeriatr. 2003;15 Suppl 1:47-52. doi: 10.1017/S1041610203008950.
4
Small vessel disease and Alzheimer's dementia: pathological considerations.小血管疾病与阿尔茨海默病性痴呆:病理学考量
Cerebrovasc Dis. 2002;13 Suppl 2:48-52. doi: 10.1159/000049150.
5
Microvascular pathology and vascular basement membrane components in Alzheimer's disease.阿尔茨海默病中的微血管病理学与血管基底膜成分
Mol Neurobiol. 1994 Aug-Dec;9(1-3):33-40. doi: 10.1007/BF02816103.
6
Alzheimer disease and cerebrovascular pathology: an update.阿尔茨海默病与脑血管病理学:最新进展
J Neural Transm (Vienna). 2002 May;109(5-6):813-36. doi: 10.1007/s007020200068.
7
The role of cerebral ischemia in Alzheimer's disease.脑缺血在阿尔茨海默病中的作用。
Neurobiol Aging. 2000 Mar-Apr;21(2):321-30. doi: 10.1016/s0197-4580(00)00125-1.
8
The blood-brain barrier and cerebral microcirculation in Alzheimer disease.
Cerebrovasc Brain Metab Rev. 1992 Fall;4(3):226-60.
9
Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease.脑血管变性与阿尔茨海默病中的β-淀粉样蛋白沉积有关。
Ann N Y Acad Sci. 1997 Sep 26;826:263-71. doi: 10.1111/j.1749-6632.1997.tb48478.x.
10
Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients.
Acta Neuropathol. 1996;91(1):6-14. doi: 10.1007/s004010050386.

引用本文的文献

1
Exploring efficient and effective mammalian models for Alzheimer's disease.探索用于阿尔茨海默病的高效哺乳动物模型。
Front Aging Neurosci. 2025 Aug 14;17:1652754. doi: 10.3389/fnagi.2025.1652754. eCollection 2025.
2
A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.血脑屏障通透性的慢性增加促进外源性血源性淀粉样β1-42肽在脑内神经元内沉积,并导致小鼠模型中与阿尔茨海默病相关的认知变化。
J Alzheimers Dis. 2024;98(1):163-186. doi: 10.3233/JAD-231028.
3
Alterations in Immune Responses Are Associated with Dysfunctional Intracellular Signaling in Peripheral Blood Mononuclear Cells of Men and Women with Mild Cognitive Impairment and Alzheimer's disease.
免疫反应的改变与轻度认知障碍和阿尔茨海默病患者外周血单个核细胞内信号转导功能障碍有关。
Mol Neurobiol. 2024 May;61(5):2964-2977. doi: 10.1007/s12035-023-03764-3. Epub 2023 Nov 13.
4
Neuroprotective effects of vinpocetine, as a phosphodiesterase 1 inhibitor, on long-term potentiation in a rat model of Alzheimer's disease.长春西汀作为磷酸二酯酶 1 抑制剂对阿尔茨海默病大鼠模型长时程增强的神经保护作用。
BMC Neurosci. 2023 Mar 16;24(1):20. doi: 10.1186/s12868-023-00790-8.
5
Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome.探索性别差异在唐氏综合征阿尔茨海默病发病机制中的作用。
Front Neurosci. 2022 Aug 12;16:954999. doi: 10.3389/fnins.2022.954999. eCollection 2022.
6
Alzheimer's Disease and Stroke: A Tangled Neurological Conundrum.阿尔茨海默病与中风:一个错综复杂的神经难题。
Cureus. 2022 May 15;14(5):e25005. doi: 10.7759/cureus.25005. eCollection 2022 May.
7
Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview.中枢神经系统疾病中的血脑屏障功能障碍及潜在治疗靶点:综述
Pharmaceutics. 2021 Oct 26;13(11):1779. doi: 10.3390/pharmaceutics13111779.
8
Brain Disorders and Chemical Pollutants: A Gap Junction Link?脑部疾病与化学污染物:存在间隙连接联系?
Biomolecules. 2020 Dec 31;11(1):51. doi: 10.3390/biom11010051.
9
The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer's Disease-related Pathogenesis.Nurr1作为阿尔茨海默病相关发病机制的介导因子和治疗靶点的关键作用。
Aging Dis. 2020 May 9;11(3):705-724. doi: 10.14336/AD.2019.0718. eCollection 2020 May.
10
The role of mutations associated with familial neurodegenerative disorders on blood-brain barrier function in an iPSC model.与家族性神经退行性疾病相关的突变在 iPSC 模型中对血脑屏障功能的作用。
Fluids Barriers CNS. 2019 Jul 15;16(1):20. doi: 10.1186/s12987-019-0139-4.